• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球临床试验中的公平性:美国临床肿瘤学会政策声明。

Global Equity in Clinical Trials: An ASCO Policy Statement.

机构信息

Al Hyatt Oncology Practice, Amman, Jordan.

National Center for Radiotherapy Ghana, Korle Bu Teaching Hospital, Accra, Ghana.

出版信息

JCO Glob Oncol. 2024 Mar;10:e2400015. doi: 10.1200/GO.24.00015.

DOI:10.1200/GO.24.00015
PMID:38484198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10954071/
Abstract

ASCO is a global professional society representing more than 50,000 physicians, other health care professionals, and advocates in over 100 countries specializing in cancer treatment, diagnosis, prevention, and advocacy. ASCO strives, through research, education, and promotion of the highest quality of patient care, to create a world where cancer is prevented or cured, and every survivor is healthy. In this pursuit, health equity remains the guiding institutional principle that applies to all its activities across the cancer care continuum. This ASCO policy statement emphasizes the urgent need for global equity in clinical trials, aiming to enhance access and representation in cancer research as it not only improves cancer outcomes but also upholds principles of fairness and justice in health care.

摘要

美国临床肿瘤学会(ASCO)是一个全球性的专业协会,代表着全球 100 多个国家的超过 50,000 名医师、其他医疗保健专业人员和癌症防治倡导者,专门从事癌症的治疗、诊断、预防和倡导工作。ASCO 通过研究、教育和倡导最高质量的患者护理,努力创造一个癌症得到预防或治愈、每个幸存者都健康的世界。在这一追求中,健康公平仍然是适用于其贯穿癌症护理连续体的所有活动的指导制度原则。本 ASCO 政策声明强调了临床试验中全球公平的迫切需要,旨在增强癌症研究中的可及性和代表性,因为这不仅可以改善癌症治疗结果,还可以维护医疗保健中的公平和公正原则。

相似文献

1
Global Equity in Clinical Trials: An ASCO Policy Statement.全球临床试验中的公平性:美国临床肿瘤学会政策声明。
JCO Glob Oncol. 2024 Mar;10:e2400015. doi: 10.1200/GO.24.00015.
2
Cancer Disparities and Health Equity: A Policy Statement From the American Society of Clinical Oncology.癌症差异与健康公平:美国临床肿瘤学会政策声明。
J Clin Oncol. 2020 Oct 10;38(29):3439-3448. doi: 10.1200/JCO.20.00642. Epub 2020 Aug 12.
3
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
4
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
5
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.临床肿瘤进展 2011:美国临床肿瘤学会癌症进展年度报告。
J Clin Oncol. 2012 Jan 1;30(1):88-109. doi: 10.1200/JCO.2011.40.1919. Epub 2011 Dec 5.
6
Role of American Society of Clinical Oncology in low- and middle-income countries.美国临床肿瘤学会在中低收入国家的作用。
J Clin Oncol. 2011 Aug 1;29(22):3097-102. doi: 10.1200/JCO.2011.35.6378. Epub 2011 Jun 27.
7
State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority Communities.美国癌症护理状况:在性少数群体和性别少数群体社区中实现癌症健康公平。
JCO Oncol Pract. 2023 Nov;19(11):959-966. doi: 10.1200/OP.23.00435. Epub 2023 Oct 4.
8
Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.电子尼古丁传送系统:美国癌症研究协会和美国临床肿瘤学会的政策声明。
J Clin Oncol. 2015 Mar 10;33(8):952-63. doi: 10.1200/JCO.2014.59.4465. Epub 2015 Jan 8.
9
Advocacy for health equity: a synthesis review.健康公平倡导:一项综合综述。
Milbank Q. 2015 Jun;93(2):392-437. doi: 10.1111/1468-0009.12112.
10
Tuberculosis结核病

引用本文的文献

1
Evaluating treatment options for symptomatic uterine fibroids: a systematic review and meta-analysis of effectiveness, recovery, and long-term outcomes (MARIE WP1).评估有症状子宫肌瘤的治疗方案:有效性、恢复情况及长期结局的系统评价和荟萃分析(MARIE项目工作包1)
Front Glob Womens Health. 2025 Jul 31;6:1601341. doi: 10.3389/fgwh.2025.1601341. eCollection 2025.
2
Real-world treatment patterns and clinical outcomes with tucatinib-based therapy in patients with HER2-positive metastatic breast cancer: analyses of two nationwide administrative health claims databases.HER2阳性转移性乳腺癌患者基于图卡替尼治疗的真实世界治疗模式和临床结局:对两个全国性行政医保索赔数据库的分析
Int J Clin Oncol. 2025 Aug 6. doi: 10.1007/s10147-025-02800-7.
3
A Podcast on Integrating Genetic Testing for Homologous Recombination Repair Gene Alterations in Patients with Prostate Cancer in the USA: a Multidisciplinary Approach to Overcoming the Obstacles.美国关于将基因检测整合用于前列腺癌患者同源重组修复基因改变的播客:克服障碍的多学科方法
Target Oncol. 2025 Jun 29. doi: 10.1007/s11523-025-01159-z.
4
Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee.支持低收入和中等收入国家迫切需要的癌症免疫疗法临床试验:SITC全球准入与影响委员会的报告
J Immunother Cancer. 2025 Jun 22;13(6):e011258. doi: 10.1136/jitc-2024-011258.
5
CDK4/6 inhibitors for metastatic breast cancer in routine clinical practice in Spain: survey of patterns of use and oncologists' perceptions.西班牙转移性乳腺癌常规临床实践中CDK4/6抑制剂的使用模式及肿瘤学家认知调查
Clin Transl Oncol. 2025 Mar 27. doi: 10.1007/s12094-025-03896-z.
6
Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally.以患者为中心的结局的全球视角:在全球推进以患者为中心的癌症临床试验。
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):35-41. doi: 10.1093/jncimonographs/lgae043.
7
"First, Trust Needs to Develop": Hematologists' Perspectives on Factors Influencing Black Persons' Participation in Clinical Trials.“首先,信任需要建立”:血液学家对影响黑人参与临床试验因素的看法。
J Racial Ethn Health Disparities. 2024 Oct 18. doi: 10.1007/s40615-024-02205-8.
8
Redefining priorities: a call for patient-centred cancer care and research.重新定义优先事项:呼吁以患者为中心的癌症护理与研究。
Nat Rev Clin Oncol. 2024 Nov;21(11):764-765. doi: 10.1038/s41571-024-00940-9.
9
Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors.免疫检查点抑制剂临床试验中少数族裔种族和民族群体的代表性不足及报告不足
JCO Oncol Pract. 2025 Mar;21(3):408-417. doi: 10.1200/OP.24.00033. Epub 2024 Aug 22.

本文引用的文献

1
Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting.全球癌症药物研发——2022 年加速抗癌药物研发与验证会议报告
JCO Glob Oncol. 2023 Sep;9:e2300294. doi: 10.1200/GO.23.00294.
2
State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority Communities.美国癌症护理状况:在性少数群体和性别少数群体社区中实现癌症健康公平。
JCO Oncol Pract. 2023 Nov;19(11):959-966. doi: 10.1200/OP.23.00435. Epub 2023 Oct 4.
3
Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments.2016 年至 2020 年全球癌症研究资金投入情况:公共和慈善投资的内容分析。
Lancet Oncol. 2023 Jun;24(6):636-645. doi: 10.1016/S1470-2045(23)00182-1.
4
A new era of the Asian clinical research network: a report from the ATLAS international symposium.亚洲临床研究网络新纪元:ATLAS 国际研讨会报告。
Jpn J Clin Oncol. 2023 Jun 29;53(7):619-628. doi: 10.1093/jjco/hyad033.
5
Funders: The missing link in equitable global health research?资助者:全球公平卫生研究中缺失的环节?
PLOS Glob Public Health. 2022 Jun 3;2(6):e0000583. doi: 10.1371/journal.pgph.0000583. eCollection 2022.
6
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050.2020 年至 2050 年全球 29 种癌症在 204 个国家和地区的全球经济成本估计和预测。
JAMA Oncol. 2023 Apr 1;9(4):465-472. doi: 10.1001/jamaoncol.2022.7826.
7
Current Scenario of Clinical Cancer Research in Latin America and the Caribbean.拉丁美洲和加勒比地区临床癌症研究的现状。
Curr Oncol. 2023 Jan 4;30(1):653-662. doi: 10.3390/curroncol30010050.
8
Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials-Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop.促进肿瘤登记试验中多样性、市场准入和能力的行动——非洲是答案吗?在加速抗癌药物研发和验证研讨会上的卫星会议报告。
JCO Glob Oncol. 2022 Jun;8:e2200117. doi: 10.1200/GO.22.00117.
9
Drug Development in Low- and Middle-Income Countries: Opportunity or Exploitation?中低收入国家的药物研发:机遇还是剥削?
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-8. doi: 10.1200/EDBK_10033.
10
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.提高癌症临床试验中的种族和民族多样性:美国临床肿瘤学会和社区癌症中心协会联合研究声明。
J Clin Oncol. 2022 Jul 1;40(19):2163-2171. doi: 10.1200/JCO.22.00754. Epub 2022 May 19.